Home > Publications database > PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells. > print

001     136720
005     20240229105054.0
024 7 _ |a 10.1016/j.ccell.2018.06.007
|2 doi
024 7 _ |a pmid:29990503
|2 pmid
024 7 _ |a pmc:PMC6048363
|2 pmc
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:44739118
|2 altmetric
037 _ _ |a DKFZ-2018-01158
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Georgilis, Athena
|b 0
245 _ _ |a PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.
260 _ _ |a Cambridge, Mass.
|c 2018
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1565615280_3741
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Oncogene-induced senescence is a potent tumor-suppressive response. Paradoxically, senescence also induces an inflammatory secretome that promotes carcinogenesis and age-related pathologies. Consequently, the senescence-associated secretory phenotype (SASP) is a potential therapeutic target. Here, we describe an RNAi screen for SASP regulators. We identified 50 druggable targets whose knockdown suppresses the inflammatory secretome and differentially affects other SASP components. Among the screen candidates was PTBP1. PTBP1 regulates the alternative splicing of genes involved in intracellular trafficking, such as EXOC7, to control the SASP. Inhibition of PTBP1 prevents the pro-tumorigenic effects of the SASP and impairs immune surveillance without increasing the risk of tumorigenesis. In conclusion, our study identifies SASP inhibition as a powerful and safe therapy against inflammation-driven cancer.
536 _ _ |a 316 - Infections and cancer (POF3-316)
|0 G:(DE-HGF)POF3-316
|c POF3-316
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Klotz, Sabrina
|b 1
700 1 _ |a Hanley, Christopher J
|b 2
700 1 _ |a Herranz, Nicolas
|b 3
700 1 _ |a Weirich, Benedikt
|0 P:(DE-He78)c9804a143404cd77d42623308f468c87
|b 4
|u dkfz
700 1 _ |a Morancho, Beatriz
|b 5
700 1 _ |a Leote, Ana Carolina
|b 6
700 1 _ |a D'Artista, Luana
|b 7
700 1 _ |a Gallage, Suchira
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Seehawer, Marco
|b 9
700 1 _ |a Carroll, Thomas
|b 10
700 1 _ |a Dharmalingam, Gopuraja
|b 11
700 1 _ |a Wee, Keng Boon
|b 12
700 1 _ |a Mellone, Marco
|b 13
700 1 _ |a Pombo, Joaquim
|b 14
700 1 _ |a Heide, Danijela
|0 P:(DE-He78)92c93319837b4b915db8393795faf0b6
|b 15
|u dkfz
700 1 _ |a Guccione, Ernesto
|b 16
700 1 _ |a Arribas, Joaquín
|b 17
700 1 _ |a Barbosa-Morais, Nuno L
|b 18
700 1 _ |a Heikenwalder, Mathias
|0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
|b 19
|u dkfz
700 1 _ |a Thomas, Gareth J
|b 20
700 1 _ |a Zender, Lars
|0 P:(DE-He78)1ba2900406378e069d32db376c7818db
|b 21
|u dkfz
700 1 _ |a Gil, Jesús
|b 22
773 _ _ |a 10.1016/j.ccell.2018.06.007
|g Vol. 34, no. 1, p. 85 - 102.e9
|0 PERI:(DE-600)2074034-7
|n 1
|p 85 - 102.e9
|t Cancer cell
|v 34
|y 2018
|x 1535-6108
909 C O |p VDB
|o oai:inrepo02.dkfz.de:136720
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)c9804a143404cd77d42623308f468c87
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)92c93319837b4b915db8393795faf0b6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)1ba2900406378e069d32db376c7818db
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|2 G:(DE-HGF)POF3-300
|v Infections and cancer
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2015
920 1 _ |0 I:(DE-He78)F180-20160331
|k F180
|l Chronische Entzündung und Krebs
|x 0
920 1 _ |0 I:(DE-He78)V076-20160331
|k V076
|l Translationale Gastrointestinale Onkologie
|x 1
920 1 _ |0 I:(DE-He78)L801-20160331
|k L801
|l DKTK Tübingen
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F180-20160331
980 _ _ |a I:(DE-He78)V076-20160331
980 _ _ |a I:(DE-He78)L801-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21